Publication | Open Access
Piperacillin pharmacokinetics in pediatric patients
22
Citations
16
References
1982
Year
Renal FunctionMedicineKidney FailureChronic Kidney DiseasePediatric PatientsPediatricsCreatinine ClearancePharmacotherapyNephrologyAntimicrobial PharmacokineticsClinical ChemistryDaily DosagePharmacologyRenal PharmacologyPharmacokinetics
The pharmacokinetics of piperacillin were studied in 15 pediatric patients (age range, 3.3 to 14.3 years). Piperacillin was administered in a dosage of 1.5 +/- 0.4 g/m2 (mean +/- standard deviation) every 4 to 6 h. Peak serum concentrations ranged from 69 to 354 micrograms/ml. The mean elimination half-life was 37.0 +/- 13.3 min, which is shorter than that observed in most adults with normal renal function. The mean elimination half-life in three patients with renal impairment was 60.1 +/- 12.4 min, and the mean ratio of renal clearance to total clearance was 0.57. These results suggest a significant nonrenal elimination of piperacillin. Based on these data, a dosage of 1.5 g/m2 given as a 30-min infusion every 4 h is suggested for children with normal renal function. For patients with renal impairment, the daily dosage could be calculated as follows: corrected dose = normal dose x (0.35 + [0.65 x (ClCr/0.06)]), where ClCr is the creatinine clearance expressed as liters per minute per square meter.
| Year | Citations | |
|---|---|---|
Page 1
Page 1